See how we've tackled industry pain points in past clinical trials. Find our latest case studies below.
ObvioHealth successfully conducted a clinical trial for RedHill Biopharma to test the safety and efficacy of an oral medication for the treatment of COVID-19 symptoms. We designed this decentralized study to be conducted where the majority of patients recover from illness—in their homes. When the trial was launched in 2021, its unique combination of home health visits, electronic patient-reported outcomes (ePRO), and remote monitoring devices was pioneering—COVID-19 studies were typically conducted inside hospitals.
ObvioHealth and Renovia conducted a groundbreaking study on the efficacy of an at-home medical device for the treatment of stress and mixed urinary incontinence. Read more below to understand how we delivered a successful, fully virtual clinical trial in the midst of the pandemic.
Lycored, a leader in carotenoid-based wellness products, sought to understand the consumer-perceived efficacy of a tomato-based supplement through twelve subjective skin indicators.
Studying a medical device for the treatment of overactive bladder. ObvioHealth is conducting an innovative study seeking FDA approval of a wearable neuromodulation device for the treatment of overactive bladder (OAB).
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.